Category:
Pandemic
Latest
Covid-19:No fans at Olympics, making Games a TV event
“The infections are in their expansion phase and everyone in this country must firmly understand the seriousness of it,” Dr Shigeru Omi, a top government medical adviser, said.
The Olympics are pushing ahead against most medical advice, partially because the postponement stalled the IOC’s income flow. It gets almost 75 per cent of its income from selling broadcast rights, and estimates suggest it would lose USD 3 billion to USD 4 billion if the Olympics were cancelled.
Global Covid-19 caseload tops 184.5 mn; deaths surge to more than 3.99 mn
COVID-19 Pandemic may lead to 95,000 additional TB deaths in India: Study
The modelling study, published in the European Respiratory Journal, estimates at least 110,000 additional deaths from TB in India, China, and South Africa unless health services maintained and strengthened
Patanjali to launch ayurvedic drug for Covid-19, claims cure within 14 days
“We appointed a team of scientists after Covid-19 outbreak. Firstly, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100 per cent favourable results,” Balkrishna said.
Coronavirus cases in India climb to 4,40,215, nearly 11,000 recoveries in single day
During the last 24 hours, a total of 10,994 COVID-19 patients have recovered, taking the recovery rate to around 56.38 per cent amongst coronavirus infected patients, an official said.
Of the 312 fresh fatalities reported till Tuesday morning, 113 were from Maharashtra, 58 from Delhi, 37 from Tamil Nadu, 21 from Gujarat, 19 from Uttar Pradesh, 14 from West Bengal, 9 from Haryana, seven each from Rajasthan and Telangana, six from Madhya Pradesh, five each from Andhra Pradesh and Karnataka, three from Jammu and Kashmir, two each from Bihar and Punjab and one each from Chhattisgarh, Goa, Odisha and Uttarakhand.
Global coronavirus cases top 9 million as outbreak surges in Brazil, India
In the United States, which has about 120,000 deaths, cases are rising again after declining for more than a month and wearing a mask is not mandatory in most states.
Insurers’ debt remains attractive to investors during COVID-19 uncertainty:S&P
Following the redemption of about $25 billion of debt between January and May 2020, the sector is set to refinance nearly $140 billion by the end of 2021 ($52 billion between June and December 2020, including about $23 billion of hybrids with upcoming call dates during this period). Half of this is due to hybrids reaching call dates and the remainder is debt coming to maturity. We recognize some insurers have already pre-financed upcoming calls or maturities,” said a S&P analysis.
IFC mobilises $2B in credit capacity from insurers to expand lending to FIs
AXA XL, Aspen Insurance, Everest Insurance®, Liberty Specialty Markets, Munich Re and Tokio Marine HCC are giving IFC the ability to significantly scale up its lending operations to emerging market financial institutions over the next four years.The initiative will allow IFC to increase its medium- and long-term lending to commercial banks and non-bank financial institutions in emerging markets by up to $5 billion.
Insurers will see take-up of cyber insurance rise following COVID-19,GlobalData
GlobalData analyst, Jazmin Chong, commented: “Cyber insurance uptake has been the most impactful among micro businesses, which saw a 300% increase between 2016 and 2019, reaching 17.8%. This huge increase is due to the very low proportion of micro businesses that held cyber insurance in the past. However, small and medium businesses have also recorded notable rises. More than 50% of medium enterprises now hold cyber insurance, highlighting the growing awareness around the importance of protection against cyber incidents among larger-sized businesses.”
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
There are currently no vaccines to prevent the coronavirus that has infected more than 9 million people and killed over 469,000 globally, and only a couple of medicines that have demonstrated benefit in hospitalized COVID-19 patients in clinical trials.
Beazley launches Contingency Policy covering virtual event organizers,offers limits of up to $10 million
London: Specialist insurer Beazley has launched a contingency policy designed to cover event organizers if a transmission failure disrupts or cancels a live virtual event. The cover is available on a global basis and offers limits of up to $10 million....
Cipla to price remdesivir version for COVID-19 under 5,000 rupees
Remdesivir, intravenously administered in hospitals, is the first treatment to show improvement in COVID-19 trials. It has been approved for emergency use in severely-ill patients in the United States, India and South Korea, and has received full approval in Japan.